139 related articles for article (PubMed ID: 6589167)
21. Human acute myelogenous leukemia antigens defined by simian antisera: evidence for leukemia-associated antigens distinct from immune response-associated alloantigens.
Mohanakumar T; Russell EC; Metzgar RS; Dunn N; Phibbs M; McWilliams NB; Maurer HM
J Natl Cancer Inst; 1979 May; 62(5):1163-7. PubMed ID: 86633
[TBL] [Abstract][Full Text] [Related]
22. [Monoclonal antibodies ICO-02 to blast cell antigens in patients with chronic myeloleukemia in blast crisis].
Baryshnikov AIu
Eksp Onkol; 1984; 6(5):53-5. PubMed ID: 6239771
[TBL] [Abstract][Full Text] [Related]
23. Antibody-targeted therapy for myeloid leukemia.
Appelbaum FR
Semin Hematol; 1999 Oct; 36(4 Suppl 6):2-8. PubMed ID: 10530710
[TBL] [Abstract][Full Text] [Related]
24. Monoclonal antibody SN2 defining a human T cell leukemia-associated cell surface glycoprotein.
Seon BK; Negoro S; Barcos MP; Tebbi CK; Chervinsky D; Fukukawa T
J Immunol; 1984 Apr; 132(4):2089-95. PubMed ID: 6607954
[TBL] [Abstract][Full Text] [Related]
25. Monoclonal antibodies reactive with acute myelogenous leukemia cells.
Linker-Israeli M; Billing RJ; Foon KA; Terasaki PI
J Immunol; 1981 Dec; 127(6):2473-7. PubMed ID: 7028873
[TBL] [Abstract][Full Text] [Related]
26. Acute myelogenous leukemia blasts as accessory cells during in vitro T lymphocyte activation.
Bruserud O; Ulvestad E
Cell Immunol; 2000 Nov; 206(1):36-50. PubMed ID: 11161436
[TBL] [Abstract][Full Text] [Related]
27. Application of series of monoclonal antibodies against human white cell differentiation antigens and the common ALL antigen in the characterization of leukemia cells.
Hołowiecki J; Stella-Hołowiecka B; Krawczyk-Kuliś M; Wiechnik E; Japa J; Jarczok K; Rudzka E; Duraj M
Arch Immunol Ther Exp (Warsz); 1984; 32(1):43-9. PubMed ID: 6433853
[TBL] [Abstract][Full Text] [Related]
28. Graft-versus-leukemia target antigens in chronic myelogenous leukemia are expressed on myeloid progenitor cells.
Wu CJ; Biernacki M; Kutok JL; Rogers S; Chen L; Yang XF; Soiffer RJ; Ritz J
Clin Cancer Res; 2005 Jun; 11(12):4504-11. PubMed ID: 15958636
[TBL] [Abstract][Full Text] [Related]
29. Characterization of a monoclonal antibody (5E9) that defines a human cell surface antigen of cell activation.
Haynes BF; Hemler M; Cotner T; Mann DL; Eisenbarth GS; Strominger JL; Fauci AS
J Immunol; 1981 Jul; 127(1):347-51. PubMed ID: 6787129
[TBL] [Abstract][Full Text] [Related]
30. Normal and malignant human myelocytic and monocytic cells identified by monoclonal antibodies.
Bernstein ID; Andrews RG; Cohen SF; McMaster BE
J Immunol; 1982 Feb; 128(2):876-81. PubMed ID: 6948042
[TBL] [Abstract][Full Text] [Related]
31. The use of myeloid-specific monoclonal antibodies in the diagnosis of leukemia.
Ball ED; Fanger MW
Diagn Immunol; 1983; 1(2):90-5. PubMed ID: 6209052
[TBL] [Abstract][Full Text] [Related]
32. Antibodies TC-12 ("unique") and TH-111 (CD96) characterize T-cell acute lymphoblastic leukemia and a subgroup of acute myeloid leukemia.
Gramatzki M; Ludwig WD; Burger R; Moos P; Rohwer P; Grünert C; Sendler A; Kalden JR; Andreesen R; Henschke F; Moldenhauer G
Exp Hematol; 1998 Dec; 26(13):1209-14. PubMed ID: 9845376
[TBL] [Abstract][Full Text] [Related]
33. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M
Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721
[TBL] [Abstract][Full Text] [Related]
34. Use of monoclonal antibodies as diagnostic and therapeutic reagents in acute lymphoblastic leukemia.
Ritz J; Pesando JM; Notis-McConarty J; Clavell LA; Sallan SE; Schlossman SF
Cancer Res; 1981 Nov; 41(11 Pt 2):4771-5. PubMed ID: 6945904
[TBL] [Abstract][Full Text] [Related]
35. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.
Raso V; Ritz J; Basala M; Schlossman SF
Cancer Res; 1982 Feb; 42(2):457-64. PubMed ID: 6948605
[TBL] [Abstract][Full Text] [Related]
36. [Flow cytometric analysis of cell surface antigens on leukemia cells by monoclonal antibodies and its application].
Takamoto S; Ueda R; Ota K; Takahashi T
Gan To Kagaku Ryoho; 1982 Jul; 9(7):1191-203. PubMed ID: 7184449
[TBL] [Abstract][Full Text] [Related]
37. C-type lectin-like molecule-1: a novel myeloid cell surface marker associated with acute myeloid leukemia.
Bakker AB; van den Oudenrijn S; Bakker AQ; Feller N; van Meijer M; Bia JA; Jongeneelen MA; Visser TJ; Bijl N; Geuijen CA; Marissen WE; Radosevic K; Throsby M; Schuurhuis GJ; Ossenkoppele GJ; de Kruif J; Goudsmit J; Kruisbeek AM
Cancer Res; 2004 Nov; 64(22):8443-50. PubMed ID: 15548716
[TBL] [Abstract][Full Text] [Related]
38. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
[TBL] [Abstract][Full Text] [Related]
39. Monoclonal antibodies against the human leukemia cell line K 562.
Böttger V; Hering S; Jantscheff P; Micheel B
Arch Geschwulstforsch; 1985; 55(1):1-8. PubMed ID: 3885895
[TBL] [Abstract][Full Text] [Related]
40. The role of platelet/endothelial cell adhesion molecule 1 (CD31) and CD38 antigens in marrow microenvironmental retention of acute myelogenous leukemia cells.
Gallay N; Anani L; Lopez A; Colombat P; Binet C; Domenech J; Weksler BB; Malavasi F; Herault O
Cancer Res; 2007 Sep; 67(18):8624-32. PubMed ID: 17875702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
